These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 31792675)
1. A novel RNA sequencing-based risk score model to predict papillary thyroid carcinoma recurrence. He J; Tian Z; Yao X; Yao B; Liu Y; Yang J Clin Exp Metastasis; 2020 Apr; 37(2):257-267. PubMed ID: 31792675 [TBL] [Abstract][Full Text] [Related]
2. A novel gene panel for prediction of lymph-node metastasis and recurrence in patients with thyroid cancer. Ruiz EML; Niu T; Zerfaoui M; Kunnimalaiyaan M; Friedlander PL; Abdel-Mageed AB; Kandil E Surgery; 2020 Jan; 167(1):73-79. PubMed ID: 31711617 [TBL] [Abstract][Full Text] [Related]
3. Low expression of Yang L; Zhang X; Zhang J; Liu Y; Ji T; Mou J; Fang X; Wang S; Chen J Future Oncol; 2022 Jan; 18(3):333-348. PubMed ID: 34756116 [TBL] [Abstract][Full Text] [Related]
4. A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma. Nam SH; Bae MR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY Oral Oncol; 2018 Dec; 87():158-164. PubMed ID: 30527232 [TBL] [Abstract][Full Text] [Related]
5. Recurrence and Complications in Pediatric and Adolescent Papillary Thyroid Cancer in a High-Volume Practice. Rubinstein JC; Herrick-Reynolds K; Dinauer C; Morotti R; Solomon D; Callender GG; Christison-Lagay ER J Surg Res; 2020 May; 249():58-66. PubMed ID: 31923715 [TBL] [Abstract][Full Text] [Related]
6. Identification of key genes of papillary thyroid carcinoma by integrated bioinformatics analysis. Xue G; Lin X; Wu JF; Pei D; Wang DM; Zhang J; Zhang WJ Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32766727 [TBL] [Abstract][Full Text] [Related]
7. Tumor Mutation Burden Predicts Relapse in Papillary Thyroid Carcinoma With Changes in Genes and Immune Microenvironment. Guo M; Chen Z; Li Y; Li S; Shen F; Gan X; Feng J; Cai W; Liu Q; Xu B Front Endocrinol (Lausanne); 2021; 12():674616. PubMed ID: 34248843 [TBL] [Abstract][Full Text] [Related]
8. A methylomics-associated nomogram predicts recurrence-free survival of thyroid papillary carcinoma. Chen H; Ma X; Yang M; Wang M; Li L; Huang T Cancer Med; 2020 Oct; 9(19):7183-7193. PubMed ID: 32783399 [TBL] [Abstract][Full Text] [Related]
9. GADD45B Transcript Is a Prognostic Marker in Papillary Thyroid Carcinoma Patients Treated With Total Thyroidectomy and Radioiodine Therapy. Barros-Filho MC; de Mello JBH; Marchi FA; Pinto CAL; da Silva IC; Damasceno PKF; Soares MBP; Kowalski LP; Rogatto SR Front Endocrinol (Lausanne); 2020; 11():269. PubMed ID: 32425887 [TBL] [Abstract][Full Text] [Related]
10. Recurrence following hemithyroidectomy in patients with low- and intermediate-risk papillary thyroid carcinoma. Ahn D; Lee GJ; Sohn JH Br J Surg; 2020 May; 107(6):687-694. PubMed ID: 32026467 [TBL] [Abstract][Full Text] [Related]
11. Correlation between telomerase reverse transcriptase messenger RNA expression and survival of patients with papillary thyroid carcinoma. Kwon JH; Yi JW Surgery; 2021 Jan; 169(1):43-49. PubMed ID: 32641280 [TBL] [Abstract][Full Text] [Related]
12. MiR-221, a potential prognostic biomarker for recurrence in papillary thyroid cancer. Dai L; Wang Y; Chen L; Zheng J; Li J; Wu X World J Surg Oncol; 2017 Jan; 15(1):11. PubMed ID: 28061868 [TBL] [Abstract][Full Text] [Related]
13. A Metabolic-associated Nomogram Predicts Recurrence Survival of Thyroid Cancer. Xi ZH; Ma XX; Chen HY; Yu YH; Li L; Huang T Curr Med Sci; 2021 Oct; 41(5):1004-1011. PubMed ID: 34510328 [TBL] [Abstract][Full Text] [Related]
14. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis. Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405 [TBL] [Abstract][Full Text] [Related]
15. Differences in the Recurrence and Survival of Patients with Symptomatic and Asymptomatic Papillary Thyroid Carcinoma: An Observational Study of 11,265 Person-Years of Follow-Up. Kim SH; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY Thyroid; 2016 Oct; 26(10):1472-1479. PubMed ID: 27457917 [TBL] [Abstract][Full Text] [Related]
16. Identifying risk factors of recurrence for clinically node negative papillary thyroid carcinoma with pathologic N1a. Ryu YJ; Cho JS; Park MH; Yoon JH BMC Surg; 2019 Jul; 19(1):78. PubMed ID: 31277631 [TBL] [Abstract][Full Text] [Related]
17. MiR-9 and miR-21 as prognostic biomarkers for recurrence in papillary thyroid cancer. Sondermann A; Andreghetto FM; Moulatlet AC; da Silva Victor E; de Castro MG; Nunes FD; Brandão LG; Severino P Clin Exp Metastasis; 2015 Aug; 32(6):521-30. PubMed ID: 26007293 [TBL] [Abstract][Full Text] [Related]
18. The value of preoperative antithyroidperoxidase antibody as a novel predictor of recurrence in papillary thyroid carcinoma. Song E; Oh HS; Jeon MJ; Chung KW; Hong SJ; Ryu JS; Baek JH; Lee JH; Kim WG; Kim WB; Shong YK; Kim TY Int J Cancer; 2019 Mar; 144(6):1414-1420. PubMed ID: 30357831 [TBL] [Abstract][Full Text] [Related]
19. Risk Factors for Recurrence After Treatment of N1b Papillary Thyroid Carcinoma. Lee SH; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY Ann Surg; 2019 May; 269(5):966-971. PubMed ID: 29462007 [TBL] [Abstract][Full Text] [Related]
20. Integrated analysis identifying new lncRNA markers revealed in ceRNA network for tumor recurrence in papillary thyroid carcinoma and build of nomogram. Chen F; Li Z; Deng C; Yan H J Cell Biochem; 2019 Dec; 120(12):19673-19683. PubMed ID: 31271223 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]